OPEN ACCESS Patented Medicines Expenditure in Canada 1990–2022 8TH Edition ATTRIBUTION This legacy paper is corporately authored and edited based on proprietary template models and methods that are intended to facilitate regular updates. The design and content are
No takes yet. Share an insight, caveat, or question.
Brett Skinner (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Canadian Health Policy